Smokers' interest in a lung cancer screening programme: a national survey in England
- PMID: 29716550
- PMCID: PMC5930691
- DOI: 10.1186/s12885-018-4430-6
Smokers' interest in a lung cancer screening programme: a national survey in England
Abstract
Background: Following the recommendation of lung cancer screening in the US, screening committees in several European countries are reviewing the evidence for implementing national programmes. However, inadequate participation from high-risk groups poses a potential barrier to its effectiveness. The present study examined interest in a national lung cancer screening programme and modifiable attitudinal factors that may affect participation by smokers.
Methods: A population-based survey of English adults (n = 1464; aged 50-70 years) investigated screening intentions in different invitation scenarios, beliefs about lung cancer, early detection and treatment, worry about lung cancer risk, and stigma. Data on smoking status and perceived chances of quitting were also collected, but eligibility for lung screening in the event of a national programme was unknown.
Results: Intentions to be screened were high in all three invitation scenarios for both current (≥ 89%) and former (≥ 94%) smokers. However, smokers were less likely to agree that early-stage survival is good (43% vs. 53%; OR: 0.64, 0.46-0.88) or be willing to have surgery for an early stage, screen-detected cancer (84% vs. 94%; OR: 0.38, 0.21-0.68), compared with former smokers. Willingness to have surgery was positively associated with screening intentions; with absolute differences of 25% and 29%. Worry about lung cancer risk was also most common among smokers (48%), and one fifth of respondents thought screening smokers was a waste of NHS money.
Conclusions: A national lung cancer screening programme would be well-received in principle. To improve smokers' participation, care should be taken to communicate the survival benefits of early-stage diagnosis, address concerns about surgery, and minimise anxiety and stigma related to lung cancer risk.
Keywords: Attitudes; Behavioural science; Early detection; Lung cancer screening; Screening uptake; Smoking.
Conflict of interest statement
Ethics approval and consent to participate
This study was exempt from ethical approval by the UCL Research Ethics Committee because it used anonymous and non-sensitive survey methods with participants who did not comprise a vulnerable group.
Competing interests
SLQ, CV, MR, SMJ, RJB and JW have no competing interests to declare. AM has received travel funding, honorariums and consultancy payments from manufacturers of smoking cessation products (Pfizer Ltd., Novartis UK and GSK Consumer Healthcare Ltd) and hospitality from North51 who provide online and database services. AM also receives payment for providing training to smoking cessation specialists; receives royalties from books on smoking cessation and has a share in a patent of a nicotine delivery device. AM is an Associate of the New Nicotine Alliance (NNA) that works to foster greater understanding of safer nicotine products and technologies.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
-
- Office for National Statistics. Statistical Bulletin Cancer Survival in England: Adults Diagnosed, 2008 to 2012, followed up to 2013. 2014. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/.... Accessed 13 Sept 2016.
-
- Eastern Cancer Registration and Information Centre. Stage distribution of cancers diagnosed in 2009 in the East of England by cancer site and area of residence. 2009. http://www.ecric.nhs.uk/docs/ECRIC_incidenceXstage_2009.pdf. Accessed 13 Sept 2016.
-
- National Lung Screening Trial Research Team. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395–409. doi: 10.1056/NEJMoa1102873. - DOI - PMC - PubMed
-
- Moyer VA. Screening for lung cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2014;160:330–338. - PubMed
-
- Centers for Medicare & Medicaid services . Decision memo for screening for lung cancer with low dose computed tomography (LDCT) (CAG-00439N) 2015.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
